131 related articles for article (PubMed ID: 8276795)
1. Construction, expression, and activity of a bivalent bispecific single-chain antibody.
Mallender WD; Voss EW
J Biol Chem; 1994 Jan; 269(1):199-206. PubMed ID: 8276795
[TBL] [Abstract][Full Text] [Related]
2. Comparative properties of the single chain antibody and Fv derivatives of mAb 4-4-20. Relationship between interdomain interactions and the high affinity for fluorescein ligand.
Mallender WD; Carrero J; Voss EW
J Biol Chem; 1996 Mar; 271(10):5338-46. PubMed ID: 8621386
[TBL] [Abstract][Full Text] [Related]
3. Efficient tumor cell lysis mediated by a bispecific single chain antibody expressed in Escherichia coli.
Gruber M; Schodin BA; Wilson ER; Kranz DM
J Immunol; 1994 Jun; 152(11):5368-74. PubMed ID: 8189055
[TBL] [Abstract][Full Text] [Related]
4. Properties of bispecific single chain antibodies expressed in Escherichia coli.
Kranz DM; Gruber M; Wilson ER
J Hematother; 1995 Oct; 4(5):403-8. PubMed ID: 8581376
[TBL] [Abstract][Full Text] [Related]
5. [Construction and characterization of bispecific single-chain antibody fragments SZ-2/SZ-21 against platelet glycoprotein Ib alpha and beta3].
Dai K; An G; Ruan C
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1493-7. PubMed ID: 12509914
[TBL] [Abstract][Full Text] [Related]
6. Leucine zipper dimerized bivalent and bispecific scFv antibodies from a semi-synthetic antibody phage display library.
de Kruif J; Logtenberg T
J Biol Chem; 1996 Mar; 271(13):7630-4. PubMed ID: 8631798
[TBL] [Abstract][Full Text] [Related]
7. Production and characterization of bispecific single-chain antibody fragments.
De Jonge J; Brissinck J; Heirman C; Demanet C; Leo O; Moser M; Thielemans K
Mol Immunol; 1995 Dec; 32(17-18):1405-12. PubMed ID: 8643110
[TBL] [Abstract][Full Text] [Related]
8. Camel single-domain antibodies as modular building units in bispecific and bivalent antibody constructs.
Els Conrath K; Lauwereys M; Wyns L; Muyldermans S
J Biol Chem; 2001 Mar; 276(10):7346-50. PubMed ID: 11053416
[TBL] [Abstract][Full Text] [Related]
9. Inter-active-site distance and solution dynamics of a bivalent-bispecific single-chain antibody molecule.
Mallender WD; Ferreira ST; Voss EW; Coelho-Sampaio T
Biochemistry; 1994 Aug; 33(33):10100-8. PubMed ID: 8060979
[TBL] [Abstract][Full Text] [Related]
10. Effect of transplantation of antibody heavy chain complementarity determining regions on ligand binding.
Gulliver GA; Voss EW
J Biol Chem; 1994 Sep; 269(39):24040-5. PubMed ID: 7523365
[TBL] [Abstract][Full Text] [Related]
11. Conversion of an anti-single-stranded DNA active site to an anti-fluorescein active site through heavy chain complementarity determining region transplantation.
Gulliver GA; Bedzyk WD; Smith RG; Bode SL; Tetin SY; Voss EW
J Biol Chem; 1994 Mar; 269(11):7934-40. PubMed ID: 8132513
[TBL] [Abstract][Full Text] [Related]
12. Construction, characterization, and mutagenesis of an anti-fluorescein single chain antibody idiotype family.
Denzin LK; Voss EW
J Biol Chem; 1992 May; 267(13):8925-31. PubMed ID: 1577730
[TBL] [Abstract][Full Text] [Related]
13. Bivalent antibody phage display mimics natural immunoglobulin.
Lee CV; Sidhu SS; Fuh G
J Immunol Methods; 2004 Jan; 284(1-2):119-32. PubMed ID: 14736422
[TBL] [Abstract][Full Text] [Related]
14. Cloning, expression, purification and characterization of a bispecific single-chain diabody against fluoroquinolones and sulfonamides in Escherichia coli.
Chen M; Wen K; Tao X; Xie J; Wang L; Li Y; Ding S; Jiang H
Protein Expr Purif; 2014 Aug; 100():19-25. PubMed ID: 24816423
[TBL] [Abstract][Full Text] [Related]
15. Expression and purification of monospecific and bispecific recombinant antibody fragments derived from antibodies that block the CD80/CD86-CD28 costimulatory pathway.
Dincq S; Bosman F; Buyse MA; Degrieck R; Celis L; de Boer M; Van Doorsselaere V; Sablon E
Protein Expr Purif; 2001 Jun; 22(1):11-24. PubMed ID: 11388794
[TBL] [Abstract][Full Text] [Related]
16. A dimeric bispecific miniantibody combines two specificities with avidity.
Müller KM; Arndt KM; Plückthun A
FEBS Lett; 1998 Jul; 432(1-2):45-9. PubMed ID: 9710248
[TBL] [Abstract][Full Text] [Related]
17. Construction of multiform scFv antibodies using linker peptide.
Wang S; Zheng C; Liu Y; Zheng H; Wang Z
J Genet Genomics; 2008 May; 35(5):313-6. PubMed ID: 18499076
[TBL] [Abstract][Full Text] [Related]
18. Anti-HLA-DR/anti-DOTA diabody construction in a modular gene design platform: bispecific antibodies for pretargeted radioimmunotherapy.
DeNardo DG; Xiong CY; Shi XB; DeNardo GL; DeNardo SJ
Cancer Biother Radiopharm; 2001 Dec; 16(6):525-35. PubMed ID: 11789029
[TBL] [Abstract][Full Text] [Related]
19. Construction, characterization, and selected site-specific mutagenesis of an anti-single-stranded DNA single-chain autoantibody.
Rumbley CA; Denzin LK; Yantz L; Tetin SY; Voss EW
J Biol Chem; 1993 Jun; 268(18):13667-74. PubMed ID: 8514799
[TBL] [Abstract][Full Text] [Related]
20. Generation of dual-variable-domain immunoglobulin molecules for dual-specific targeting.
Gu J; Ghayur T
Methods Enzymol; 2012; 502():25-41. PubMed ID: 22208980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
